Relation of C-reactive protein to endothelial fibrinolytic function in healthy adults

American Journal of Cardiology

Volumn 108, Issue 11, 2011, Pages 1675-1679

  Weil, Brian R ^a   Greiner, Jared J ^a   Desouza, Christopher A ^a,b   Stauffer, Brian L ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; C REACTIVE PROTEIN; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; ENDOTHELIUM; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; IN VIVO STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN SECRETION;

C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; REFERENCE VALUES;

EID: 80955158526     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.026     Document Type: Article

References (26)

1. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr, K. Taubert, R.P. Tracy, F. Vinicor Centers for Disease Control and Prevention, American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
2. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
3. T.G. Lohman, A.F. Roche, and R. Mortorelli Anthropometric Standardization Reference Manual 1988 Human Kinetics Champaign, IL
4. G.L. Hoetzer, B.L. Stauffer, H.M. Irmiger, M. Ng, D.T. Smith, and C.A. DeSouza Acute and chronic effects of oestrogen on endothelial tissue-type plasminogen activator release in postmenopausal women J Physiol 551 2003 721 728
5. G.P. Van Guilder, G.L. Hoetzer, D.T. Smith, H.M. Irmiger, J.J. Greiner, B.L. Stauffer, and C.A. DeSouza Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise Am J Physiol Endocrinol Metab 289 2005 E807 E813
6. S. Jern, U. Wall, A. Bergbrant, L. Selin-Sjögren, and C. Jern Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension Arterioscler Thromb Vasc Biol 17 1997 3376 3383
7. H. Chaplin Jr, and P.L. Mollison Correction for plasma trapped in the red cell column of the hematocrit Blood 7 1952 1227 1238
8. R.F. Macko, S.F. Ameriso, A. Gruber, J.H. Griffin, J.A. Fernandez, R. Barndt, F.P. Quismorio Jr, J.M. Weiner, and M. Fisher Impairments of the protein C system and fibrinolysis in infection-associated stroke Stroke 27 1996 2005 2011
9. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
10. P.M. Ridker C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus J Am Coll Cardiol 49 2007 2129 2138
11. S.J. Cleland, N. Sattar, J.R. Petrie, N.G. Forouhi, H.L. Elliott, and J.M. Connell Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (Lond) 98 2000 531 535
12. S. Fichtlscherer, G. Rosenberger, D.H. Walter, S. Breuer, S. Dimmeler, and A.M. Zeiher Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Circulation 102 2000 1000 1006
13. F. Tomai, F. Crea, A. Gaspardone, F. Versaci, A.S. Ghini, L. Chiariello, and P.A. Gioffr Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion Circulation 104 2001 1471 1476
14. R.J. Bisoendial, J.J. Kastelein, S.L. Peters, J.H. Levels, R. Birjmohun, J.I. Rotmans, D. Hartman, J.C. Meijers, M. Levi, and E.S. Stroes Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects J Lipid Res 48 2007 952 960
15. D.E. Newby, R.A. Wright, C. Labinjoh, C.A. Ludlam, K.A. Fox, N.A. Boon, and D.J. Webb Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction Circulation 99 1999 1411 1415
16. J.J. Oliver, D.J. Webb, and D.E. Newby Stimulated tissue plasminogen activator release as a marker of endothelial function in humans Arterioscler Thromb Vasc Biol 25 2005 2470 2479
17. M. Cushman, R.N. Lemaitre, L.H. Kuller, B.M. Psaty, E.M. Macy, A.R. Sharrett, and R.P. Tracy Fibrinolytic activation markers predict myocardial infarction in the elderly The Cardiovascular Health Study Arterioscler Thromb Vasc Biol 19 1999 493 498
18. P.M. Ridker, C.H. Hennekens, M.J. Stampfer, J.E. Manson, and D.E. Vaughan Prospective study of endogenous tissue plasminogen activator and risk of stroke Lancet 343 1994 940 943
19. P.M. Ridker, D.E. Vaughan, M.J. Stampfer, J.E. Manson, and C.H. Hennekens Endogenous tissue-type plasminogen activator and risk of myocardial infarction Lancet 341 1993 1165 1168
20. S.D. Robinson, C.A. Ludlam, N.A. Boon, and D.E. Newby Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease Arterioscler Thromb Vasc Biol 27 2007 1651 1656
21. W.S. Speidl, A. Zeiner, M. Nikfardjam, A. Geppert, N. Jordanova, A. Niessner, G. Zorn, G. Maurer, W. Schreiber, J. Wojta, and K. Huber An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion J Am Coll Cardiol 45 2005 30 34
22. U. Singh, S. Devaraj, and I. Jialal C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant Arterioscler Thromb Vasc Biol 25 2005 2216 2221
23. T. Nyström C-reactive protein: a marker or a player? Clin Sci (Lond) 113 2007 79 81
24. E. Ulfhammer, P. Larsson, L. Karlsson, T. Hrafnkelsdóttir, M. Bokarewa, A. Tarkowski, and S. Jern TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent J Thromb Haemost 4 2006 1781 1789
25. K. Kugiyama, T. Sakamoto, I. Misumi, S. Sugiyama, M. Ohgushi, H. Ogawa, M. Horiguchi, and H. Yasue Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells Circ Res 73 1993 335 343
26. M.A. Shatos, J.M. Doherty, D.C. Stump, E.A. Thompson, and D. Collen Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture J Biol Chem 265 1990 20443 20448